Research programme: heparanase inhibitors - Dr Reddy's LaboratoriesAlternative Names: DRF 8439; Heparanase inhibitors research programme - Dr Reddy's Laboratories
Latest Information Update: 04 Aug 2010
At a glance
- Originator Dr Reddys Laboratories
- Mechanism of Action Heparanase inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- No development reported Solid tumours
Most Recent Events
- 14 Apr 2004 Preclinical trials in Solid tumours in USA (unspecified route)
- 14 Apr 2004 Preclinical trials in Solid tumours in India (unspecified route)